Hollywood spent Q3 daydreaming about the next “Obsession.” Curry Barker’s dating-horror was produced for a reported $750,000 and has grossed more than $500 million worldwide. That is the kind of outlier that turns a shopping brief into limerence—an all-consuming fixation that, as psychologist Dorothy Tennov defined it, feeds on imagined reciprocation rather than evidence. The actual Q3 horror numbers tell a more useful story: there is money in the genre, but it comes in different shapes, and measuring every release against one freak result leads to wrong conclusions.
Big openings don’t equal staying power
Zach Cregger’s “Resident Evil” opened to $60.2 million domestically, more than triple the $17.2 million that launched “Obsession” in May. Through 13 days, “Resident Evil” had collected $110.6 million, well ahead of “Obsession’s” $73.5 million over the same stretch. But the two trajectories diverged fast. “Resident Evil” fell 62 percent in its second weekend; “Obsession” had grown 39 percent and then added another 14 percent in weekend three. The comparison is not a verdict on profitability—“Resident Evil” carried a reported $75 million production budget, while “Obsession’s” tiny spend makes its multiples exceptional. It is a reminder that horror buzz can come from anticipation, as with a known director and IP, or from the shock of exceeding expectations, as with an unknown original.
Buddy shows the realistic indie win
Casper Kelly’s “Buddy” ended September with $26.6 million domestically against a reported $3 million production budget. That is almost five times its $5.5 million opening, and it never played more than 1,771 theaters. It even grew 6 percent in its second weekend before a manageable 38 percent drop. Distributors Roadside and Saban leaned into Kelly’s Adult Swim pedigree, teasing the sinister underside of a familiar children’s-TV format and giving audiences a specific reason to be curious. The lesson is not that “Buddy” is the next “Obsession”; Fangoria explicitly cautioned it would not make $500 million. The lesson is that a distinctive indie horror can become a meaningful theatrical run if it is given room to expand, rather than being written off for failing to match a once-in-a-decade event.
Franchise wear and the right benchmarks
Sequels have more relevant comparisons than “Obsession”: their own previous installments. Sony’s “Insidious: Out of the Further” opened to $25.1 million domestically and reached $65.4 million by September 30. That opening was down 24 percent from 2023’s “The Red Door,” but with a reported $18 million budget and $168.3 million worldwide by October 4, it remains commercially strong. Warner Bros.’ “Evil Dead Burn” had a sharper contraction: a $13.7 million opening, $32.2 million domestic, and $72.4 million worldwide versus “Evil Dead Rise’s” $67.4 million domestic and $147.3 million worldwide—despite the production budget rising from $15 million to $20 million. Spending more to reach a smaller audience is a real problem, but it is a franchise-level problem, not an “Obsession” problem.
For limited releases, the right rubric is trajectory and per-theater strength, not raw gross. Jane Schoenbrun’s “Teenage Sex and Death at Camp Miasma” opened in five theaters with a per-theater average just under $50,000, expanded to 1,036 locations, and finished with $6.8 million domestically. That is roughly 37 percent ahead of Schoenbrun’s 2024 film “I Saw the TV Glow,” which peaked at 469 theaters. It suggests a larger theatrical audience was found, though the industry should still ask how well that interest survived expansion. Alex Ullom’s “It Ends” made about $1 million from a peak of 340 theaters and dropped off quickly—a signal to examine release cost and whether streaming might have served it better.
- Benchmark sequels against their own franchise history, not the “Obsession” outlier.
- For indies, track budget-to-gross multiples and second-weekend holds, not the $500 million dream.
- For limited releases, use per-theater average and expansion trajectory—and ask whether streaming is the better window.
What to watch in October
The hunt for the next YouTube-borne breakout continues. Markiplier’s “Iron Lung” opened to $18.2 million domestically in January on a reported $3 million budget, and the Q3 slate brought no comparable digital-platform arrival. October tests are already live: Hades Films opened “The Influencer Project,” starring Chiara King, on October 2, and will later partner with Dead Meat’s James A. Janisse and Chelsea Rebecca for “Fresh Meat,” an anthology built from over 500 submissions with audience voting. Those are concrete bets on creator-led discovery, and they land alongside “Other Mommy,” “Whalefall,” “Crawlers,” and “Clayface” in the Halloween corridor.
The horror business does not need another “Obsession” to validate itself. It needs decision-makers who can read a range of results—big opening, slow burn, franchise decline, limited release—as separate signals, not as failures to become the exception.
Source: IndieWire
